Description: Risk adjustment (RA) is a key component for CMS Medicare Advantage program and California Medicaid Managed Care program. While both RA programs follow generally accepted basic principles at a high level, their underlying methodologies and assumptions are also quite different. Due to recent events such as COVID-19 Public Health Emergency and Medicaid redetermination delay and restart, it adds complexity to Risk Adjustment. This is a hot topic in the industry and has significant impact to health plans. Keeping current with risk adjustment program changes and understanding the commonalities and differences of these two government risk adjustment programs is important to our health actuaries. Compare these two risk adjustment programs so you can learn key elements of a risk adjustment program, similarities and differences in methodology and assumptions , as well as special considerations due to serving different populations.

Description: "A crucial importance in forecasting is to be able to distinguish cases when temporary slowdowns in health care utilization are followed by a “rebound” period of higher utilization. Come explore an analysis of a new mathematical model describing the return-of-care process. By means of simulation and case studies using the R programming language, the relationship between the visibility of these effects and the endogenous variance of the utilization time series is explored. After attending this session, you will be able to: Describe the parameters and mathematical form of the model Apply the model to real-world utilization data"

Description: This webcast will walk through several statistical methods for imputing race and ethnicity from U.S. datasets, highlighting their strengths and weaknesses, talking about how to use them and evaluating their accuracy, and telling you where you can get code packages as well as a free dataset to try the methods out.

Description: This session will discuss essential theories and practical applications of deep learning for actuaries. Participants will gain insights on leveraging these cutting-edge techniques to enhance actuarial models and drive predictive accuracy.

Description: Artificial intelligence brings immense opportunities for productivity gains—and valid concerns. It can both support innovations in insurance products and in the customer experience as well as enhance our profession’s work. Actuaries share a responsibility for caution and professional judgment to use it without jeopardizing the fair and equitable treatment of individual consumers and the principals we serve.AI creates significant challenges for consumers: opacity, reliable accuracy, privacy, and verification of personal data. The Academy and its members have been working to educate and inform stakeholders, insurance commissioners, and regulators toward improving the transparency of algorithms that underlie the use of AI by insurers, to explain how the algorithms can be used to achieve equitable treatment, and to identify the issues and trade-offs related to ensuring consumer protections. We must amplify the actuarial perspective on how adequate disclosures, documentation, and governance of AI can help protect users. This session will examine how we can govern and support the evolution of better practices. We will discuss how AI is addressed via standards such as ASOP No. 56, Modeling, and other guardrails that are being developed to best utilize AI’s real-world potential and fulfill our professional responsibilities.

Description: This session includes a new idea based on dynamic treatment regime work (OWL) and integrating cost into this work. This will enable identifying the best treatment for a patient based on both outcomes and cost. This is novel for actuaries because in previous analysis we have used cost only in the after-analysis, whereas here we use it in the actual analysis and treatment identification. Moreover, this analysis provides a way to consider multiple treatments for a patient (including the no treatment option) and choosing among those multiple treatments, for both outcomes and cost. This session will share the background theory and set up a case study. The case study will parallel what is in the analysis in the book by Ian Duncan 'Predicting Hospital Readmission with Case Management Recommendation.' This analysis will then go further to compare a situation where there are multiple potential case managers. Also, this will potentially explore care pathways and choosing the best care pathway for a patient based on health outcomes and cost combined.

Description: Further explore the pipeline of large claims approaching in the future in this webcast. Some of these upcoming claims include Cell and Gene Therapies, as well as high medical costs. In order to prepare for the multitude of claims, this session provides the insurance industry with an overview of what these large claims consist of. You can also expect important recommendations on how to properly prepare for them to succeed in this market.

Description: Regression to the mean (RTTM) is inflating your health care intervention evaluations if you are not carefully managing it's omnipresent and significant impact RTTM is the statistical phenomenon which arises when comparing sequential data points when an initial observation is extreme or an outlier, and states that with no other intervention, future observations will be closer to the average. Members who had high costs last year will, on average, have lower costs this year, even in the absence of any intervention or clinical program, simply by 'regressing' to the mean. This means that if your clinical programs are simply targeting members who had adverse medical experience last year, you’re targeting the wrong people. And if your savings methodologies are simply last year’s costs minus this year’s costs, the savings are inflated. By attending this session, you will be able to identify situations where RTTM will be a significant factor, how to eliminate it's impact when performing retrospective evaluations, how to identify prospects for clinical intervention with RTTM in mind, and more.

Description: Pandemics are a main driver of losses for both life and non-life (re-)insurance. Until COVID-19, risk assessment mostly relied on a few historic examples, most importantly the Spanish flu. The COVID-19 pandemic has shown that other pathogens (namely the coronaviruses) need to be taken into account. Also, modern societies and governments drastically respond to novel threats and implement measures such as social distancing, mask mandates, and lockdowns. Besides the properties of the pathogen itself, these reactions and the medical progression (namely the development of vaccines) are key influences on the course of a pandemic, and thus also the resulting outcomes. To account for the new insights, join us as we take a look at a stochastic, age-structured compartmental model that is calibrated on recent pandemics with several parameters sets to model different levels of reaction speed and stringency between groups of countries. Other important factors also must be defined in close collaboration with experts. Get ready to explore the development of a model and framework that can provide potential outcomes to be used as the basis to derive both summary and tail statistics to assess pandemic risk and help price complex deals.

Description: Artificial Intelligence (AI) has become a key component of the insurance landscape and getting full value from an AI depends on much more than simply building the model. Please join us to hear the challenges and potential solutions around successfully deploying an AI-driven initiative within an organization. Hear from panelists as they describe the human impacts of model implementation, how to assess a model for effectiveness and (lack of) bias, and detail the journey of implementing AI-driven underwriting models at a large insurance company.